Study the effect of high sensitive-C reactive protein in newly diagnosed acute myeloid leukemia with other hematological markers Obed Fatma Abdalhamza1, Shafeeq Noorhan Khalid2,*, Akram Raghda Shams3, Hmeed Elaf Zuhair4 1Hematological Center, Al-Mustansiriya University, Baghdad, Iraq 2Department of Chemistry / College of Education, For Pure Science, (Ibn-Al-Haitham) University of Baghdad, Iraq 3Department of chemistry and Biochemistry, College of Medicine, Mustansiriyah University, Baghdad, Iraq 4Hematological Center, Al-Mustansiriya University, Baghdad, Iraq *Corresponding Author E-mail: aliomran662000@yahoo.com, noorhan.albayaty@gmail.com
Online Published on 10 October, 2023. Abstract Acute myeloid leukemia (AML) is a clonal disease that manifests itself in the bone marrow as a hyper proliferative immature myeloid cells with a defective differentiation program. In adults, Acute leukemia is the most frequent type of cancer. The most common causes of death among patients include severe infections, resistance, and relapses. Recent research has suggested that the disease is caused by a collection of hematopoietic stem cell mutations accumulated over time. the study was carried out to detect how high sensitive C-reactive protein (hs-CRP) affected newly diagnosed Acute Myeloid Leukemia patients with other co morbidity and diabetes insipidus.in Conclusion; Increased high sensitive (c-reactive protein) (hs-CRP) could be act as predictive factor in individuals with diabetes and other hematological changes who have acute myeloid leukemia. Aim of Study The study was carried out to detect how high sensitive C-reactive protein (hs-CRP) affected newly diagnosed Acute Myeloid Leukemia patients with other co morbidity and diabetes insipidus. Conclusion Increased high sensitive (c-reactive protein) (hs-CRP) could be act as predictive factor in individuals with diabetes and other problem who have acute myeloid leukemia. Furthermore the causes between association with diabetes insipidus are not understood. Top Keywords Acute myeloid leukemia. Top |